Neurology

Article	Citations
Intravenous Immune Globulins vs Plasma Exchange Usage in Patients with Neuromuscular and Neuro-immunological Conditions (P4-13.007)	811
Increased Healthcare Cost and Mental Health Burden among Patients with Essential Tremor: A Retrospective Observational Study in A Large US Commercially Insured and Medicare Advantage Population (P15-1	282
Postpartum Risk of Cerebral Venous Thrombosis (P10-10.006)	248
Towards Machine Learning-Based Cognitive Examination (S2.010)	234
Reduced Time to Treatment After Implementation of a Standardized Guideline for the Diagnostic Evaluation and Acute Management of Suspected Autoimmune Encephalitis in Hospitalized Adult Patients (P9-8.	203
Teaching NeuroImage: Foramen Magnum Dural Arteriovenous Fistula Presenting With Thoracolumbar Myelopathy	198
Spinal Cord Infarction Associated with Patent Formale Ovale and Venous Thromboembolism: A Case Report (P8-13.005)	195
Standardized Inpatient Telestroke to Improve Access to Stroke Specialists (P12-14.015)	160
Improving Median Overall Survival (OS) of Glioblastoma (GBM) Patients by Optimizing Standard of Care (SOC) Through Multidisciplinary Team Work and Combination Therapies Including Tumor Treating Fields	157
Role of the UNC13 Family in Human Diseases: A Literature Review (P9-2.003)	154
Frailty increases the risk of Alzheimer’s disease in non-demented individuals: a longitudinal cohort study (P6-3.008)	154
Predicting Cognitive Decline Using Baseline Data in Cognitively Unimpaired Older Adults: Results from the A4 Trial (P2-3.018)	148
Rational Design of a Vaccine for Synucleinopathies Using Computationally-Derived Conformational B Cell Epitopes To Selectively Target Pathogenic Alpha-Synuclein Species (P8-3.007)	143
Traumatic Brain Injury and Depressive Symptoms in Community Dwelling Older Adults (P3-4.007)	139
The Boston Criteria v2.0 for Cerebral Amyloid Angiopathy	133
Lifestyle Contributors to Frequent Headaches in Youth	132
Multicenter Post-approval Study of the RNS System in Focal Epilepsy (S20.009)	131
Exploring Clinical Outcomes of ABCDEF Bundle Implementation in Neurocritical Patients: Insights from Two Years of ICU Humanization (P9-7.006)	130
Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine (P4-12.005)	121
Frequency and Severity of Neurological Symptoms Following Gluten Exposure in Individuals with Celiac Disease (P1-2.010)	121
Association Between COVID-19 Vaccination and Rhabdomyolysis in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study (S18.006)	121
Analysis of the Efficacy of Efgartigimod in a Refractory OMG Patient (P1-11.019)	121
A Clinical Decision Rule Predicting Outcomes of Emergency Department Patients with Altered Mental Status (P5-12.003)	119
Vision-Specific Quality of Life in Patients with Post-Acute Sequelae of COVID-19 (PASC) (P18-12.005)	117
Association Between COVID-19 Vaccination and Cerebrovascular Accidents in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study (S18.002)	115

A Clinical Bulbar Assessment Scale for ALS/MND: Preliminary Validation (S11.007)	114
Cenobamate Plasma Concentrations in Patients Reaching ≥50% or 100% Responder Rates for ≥12 Months: A Post-hoc Analysis (S13.004)	112
Peripheral Neuropathy	107
Teaching Video NeuroImage: Pattern-Induced Seizures Without Photosensitivity in Glutaric Aciduria	101
Development and Validation of a Nomogram Prediction Model for New Stroke in Community Population (P10-13.004)	99
Perspectives From Members of an Online Community on Their Communications With Health Care Professionals About Migraine Treatment: A Social Listening Analysis (P17-2.003)	94
Author Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM	93
Author Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM	93
Variation in Resting Metabolic Rate Affects Identification of Metabolic Change in Geographically Distinct Cohorts of Patients With ALS	87
Bilateral temporal lobe epilepsy: How many seizures are required in chronic ambulatory electrocorticography to estimate the laterality ratio? (S7.010)	84
Amyloid beta deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort (P1-1.Virtual)	83
Early Neurological Improvement Can Reduce Intensive Care Unit Length of Stay in Aneurysmal Subarachnoid Hemorrhage (P12-10.008)	82
Pathogenic Th17 Cells in Autoimmune Myasthenia Gravis Exhibit a Pro-inflammatory Transcriptomic Signature that Promotes Disease Pathogenesis (S41.008)	79
Motor Outcomes to Validate Evaluations in Facioscapulohumeral muscular dystrophy (MOVE FSHD): Protocol for an observational study. (S29.007)	79
Quantitative Cerebrovascular Reactivity Atlas In Children (P14-5.003)	77
Resting-state Regional Cerebral Blood Flow Alterations in Macrovasculature and Microvasculature in Parkinson’s Disease: A Systematic Review and Meta-analysis (P3-5.013)	77
Completing the NIHSS Score Prior to CT Scan to Reduce Time to Acute Intervention for Stroke: A Quality Improvement Project (P17-10.008)	77
Long-term Treatment with Galcanezumab in 29 Patients with Chronic Migraine: Results from the 3-year Continued Access Program of the REGAIN Study (P1-1.Virtual)	77
Adaptive B-cell and T-cell responses to SARS-CoV-2 vaccination in patients with Multiple Sclerosis on disease modifying immunotherapy (S5.006)	77
Rethinking Thunderclap Headaches: A Critical Look at Cerebral Venous Sinus Thrombosis (P3-13.020)	75
Exploring Racial Disparities in Advanced Care Planning Documentation for Stroke Patients (P10-13.020)	75
Automated Data Extraction Using Large Language Models in Vascular and Interventional Neurology Research: Towards an AI Fully Assistant Automated Research (P9-14.007)	74
Demographic and Regional Trends of Meningitis-related Mortality in the United States from 1999 to 2020: a CDC WONDER Analysis (P3-10.004)	73
Brain Perfusion Imaging and Cardiac Thrombus Detection	73
Effectiveness of Ataluren in Patients with nmDMD: Confirmatory Evidence from the STRIDE Registry (P7-6.008)	73
IgG4-Related Hypertrophic Pachymeningitis Mimicking Neuromyelitis Optica: a Case Report (P10-8.004)	72
Diagnosis and Management of Adult Status Epilepticus in Resource-Limited Settings	72
Patient Education and Unmet Needs: Pregnancy and Postpartum Counseling in MS (P6-1.014)	71
Capturing Patient and Caregiver Perspectives on Parkinson’s Disease in Zambia: A Methodology (P6-11.014)	71
Modifiable Vascular Risk Factors and Subsequent Brain Metrics in Hispanic/Latino Populations	71
Elevated Pre-hospital Blood Pressure is Associated with Reduced Infarct Volume in Large Vessel Occlusion Ischemic Strokes (P12-13.016)	69
Clinical and Genetic Profiles of Congenital Myasthenic Syndromes: A Single Tertiary Care Center Experience from Saudi Arabia (P12-11.029)	69
Evaluating Brain Health in Women	69
Teaching Video NeuroImage: Reflex Epilepsy—Seizures Triggered by a Geometric Pattern	68
Distinguishing Quantitative EEG Correlates of Psychogenic Non-Epileptic Seizures versus Epilepsy (P1-1.Virtual)	68
Descriptive Analysis of Acute Ischemic Stroke in COVID-19 Patients Through The Course of COVID-19 Pandemic (P18-10.009)	67
Clinical evidence that treatment with pepinemab, a novel regulator of neuroinflammation, provides cognitive benefit to patients with Huntington’s and potentially other neurodegenerative diseases (P3-1	67
Diagnosis of Stroke and Prognosis of Interventions Using Imaging and Machine Learning (P1-1.Virtual)	66
Residual Symptoms and Long-term Outcomes after All-Cause Autoimmune Encephalitis (P5-1.002)	66
Sustainability of Seizure Control With Adjunctive Cenobamate in the Phase 3 C021 Study (P12-8.001)	65
Real-World Experience of Perampanel Monotherapy in Epilepsy Patients with Focal-Onset and Generalized-Onset Seizures (P15-8.002)	65
Long-term survival and cognitive function follow up of primary CNS lymphoma treated with R-MVP followed by high dose chemotherapy with autologous stem cell transplant consolidation (S27.008)	65
Study Design of AOC 1001-CS1, a Phase 1/2 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Patients with Myoton	65
Open-ended, value-based decision making requires semantic memory: a computational, imaging, and clinical study (P1-6.005)	64
BRAT1 Associated Leukodystrophy exacerbated by Lymphoma directed Chemotherapy (P13-9.005)	64
The Association of Posterior Reversible Encephalopathy Syndrome with COVID-19: A Systematic Review (P1-1.Virtual)	64
Ponesimod Shows Improved Effect on Brain Volume Compared with Other DMTs, A Model Based Meta-Analysis (P1-1.Virtual)	64
Serving Los Angeles County Patients with Teleneurology, A Clinical Tool Here to Stay (P18-8.007)	63
Novel Ischemic Stroke Treatment Protocol for Salvageable Penumbra in Acute Small Vessel Disease (S6.010)	63
Delayed Toxic Encephalopathy Masquerading as Creutzfeldt-Jakob disease (P2-9.007)	62

Prevalence of Comorbidities in a National Sample of Lewy Body Dementia Caregivers (P15-3.005)	62
Improved Access to Rapid Electroencephalography at a Community Hospital Reduces Inter-Hospital Transfers for Suspected Non-Convulsive Seizures (P6-8.003)	62
Cardiac MRI in Duchenne and Becker Muscular Dystrophy (P14-13.001)	62
Temporal Mapping of Trigeminal Neuralgia Lesions to Symptom Onset in Multiple Sclerosis: When Do the Lesions Occur and What Do They Tell Us? (P16-4.001)	62
A Novel IONM Protocol for Distal Femoral Extension Osteotomies (P6-6.010)	61
Artificial intelligence identifies spectral biomarkers for use in adaptive deep brain stimulation in Parkinson’s disease (S16.004)	61
Comparison of Pharmacokinetic Profiles and Safety Outcomes with Peginterferon Beta-1a Administration in Black/African American and White Participants (P4-4.009)	61
Having Second Thoughts About Parkinson Diagnosis	60
Case Report of a Unique Structural Cause for Rapidly Progressive Orthostatic Syncope (P7-2.001)	60
Overdiagnosis of Autism Spectrum Disorder: Diagnostic and Management Challenges in a Pediatric Outpatient Clinic (P6-6.003)	60
VGL101: An Immunotherapy that Enhances Microglial Survival for Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) (P9-9.013)	60
Hereditary Transthyretin Amyloidosis at Geisinger Medical Center: A Four-year Multidisciplinary Clinic Experience (P6-11.033)	60
Outcomes of a Three Week Interdisciplinary Intensive Outpatient Treatment Program for Mild-Moderate Traumatic Brain Injury in Veterans and First Responders (P7-4.006)	60
Wobbling Through the Spectrum: Anti-GQ1b Antibody Syndrome Presenting with Generalized Myoclonus and Ataxia (P4-8.018)	60
Distinguishing Features of MOG Positive and MOG Negative Pediatric Patients with ADEM (S2.008)	59
Consent Deviations in an Acute Ischemic Stroke Clinical Trial (P5-13.017)	58
Quantitation of Hypocretin Neuropeptides (Orexin-A and -B) in Human Cerebrospinal Fluid via HPLC with MS/MS Detection (P1-4.002)	58
NETSseq Identifies Novel Therapeutic Targets for Neurodegenerative Diseases (P3-3.008)	58
The Role of Endothelin-1 in Hypoxia-Induced Inflammation and Oxidative Stress in Microglial Cells (P4-13.001)	58
Effect Sizes of Once-daily Valbenazine for Chorea Associated with Huntington’s Disease: A Post-hoc Analysis of KINECT®-HD Data (P10-5.012)	57
Colchicine Use and Risk of Stroke Recurrence in Acute Non-Cardiogenic Ischemic Stroke Patients: A Systematic Review and Meta-analysis (P4-14.006)	57
Pediatric SMART Syndrome in a 10-year-old boy: A Case-Report (P5-6.005)	57
Spontaneous Closure Of A Dural Arteriovenous Fistula: A Case Report (P5-14.011)	56
Pearls & Oy-sters: Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Presenting as Encephalomyelitis With Leptomeningeal Enhancement	55
Localizing Lesions in the Peripheral Nervous System using Generative Artificial Intelligence (P1-2.009)	55
The Midbrain Paradox: Bilateral Vertical Gaze Palsy from a Single Sided Lesion (P2-11.007)	54
Inter-Institutional Collaborative Opportunity For Medical Students in the Neurosciences: Annual Student Interest Group in Neurology (SIGN) Forum (P5-5.021)	54
Severity of Hearing Loss as a Predictor of Dementia Risk: Insights from the ARIC Study (P9-3.013)	54
Radiological Signs in Spinal Cord Infarct (SCI) and Association with Anatomic Location. (P9-13.005)	54
Teaching Neuro Images : CNS actinomycosis in an immunocompetent patient	53
Multimodal Regression Based Assessment of Longitudinal Evolution Trends in Inflammatory Myositis (IIM) (P3-11.018)	53
Functional Eloquence Weighted Imaging	53
Reader Response: Teaching NeuroImage: Cryptococcal Meningoencephalitis With Cryptococcoma and Gelatinous Pseudocysts	53
Comment: Introducing Neuromodulation in 2035	53
Teaching NeuroImage: Seizures as the Initial Symptom of Relapsing Polychondritis	52
Reader Response: Use of Social Media in Health Care—Opportunities, Challenges, and Ethical Considerations: A Position Statement of the American Academy of Neurology	52
Measles, Rubella, and Varicella-Zoster Viral Antibodies and Clinical Prognosis After 20 Years in Persons with Multiple Sclerosis	51
My First Patient With Alzheimer's	51
Incidence of Relapses After Meningococcal Vaccination in Clinical Trials of Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)	51
Assessing the Impact of Immune Checkpoint Inhibitor Therapy on Disease Activity in Multiple Sclerosis Patients	50
Neuropsychologic Impact of MOGAD: A Patient Reported Outcomes Study	50
Characterization of Clinical Course, Diagnosis, Treatment, and Outcomes of Intravascular Lymphoma with Neurologic Involvement	50
Comparative Efficacy of Adjuvant Rifampicin, Levofloxacin, and Their Combination in Tuberculous Meningitis With and Without HIV Co-infection: A Systematic Review and Meta-Analysis	50
Characterizing Double-Negative Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis	50
NMDA Receptor Encephalitis With Severe Orofacial Dyskinesias Treated With Tramadol and Clonazepam	49
A Broader Perspective on Motor Rehabilitation Guidelines for Cerebral Palsy	49
Association of Blood Pressure Variability With Death and Discharge Destination Among Critically Ill Patients With and Without Stroke	49
Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis	49
Contributions of Purine Synthesis and Recycling During Brain Development: Relevance to Lesch Nyhan Disease (S39.009)	49
Coexistance of Probable Neurosarcoidosis and Generalized Myasthenia Gravis: Case Report	49
[ 11 C]PK11195-PET Brain Imaging of the Mitochondrial Translocator Protein in Mitochondrial Disease	49
Author Response: D313Y Variant in Fabry Disease: A Systematic Review and Meta-analysis	49
Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial	48
Seizure Forecasting by High-Frequency Activity (80–170 Hz) in Long-term Continuous Intracranial EEG Recordings	48
Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent	48
Pearls & Oy-sters: Tumefactive Demyelinating Lesions With MOG Antibodies Preceding Late Infantile Metachromatic Leukodystrophy	48
The Importance of Offering Genetic Counseling and Testing to All Persons Diagnosed With Frontotemporal Degeneration Spectrum Disorders	48
New Requirements in the Reporting of Randomized Controlled Trials Published in Neurology to Foster Greater Transparency	48
Screening for Congenital Myasthenic Syndromes in Adults With Seronegative Myasthenia Gravis Using Next-Generation Sequencing	48
Classifying Papilledema Using Machine Learning – Modernizing Frisén Grading (S12.001)	48
Reliability of Reachable Workspace (RWS) Measurement System in a Large, Multi-Site, International FSHD Clinical Study (P13-13.002)	48
Association of Circulating Metabolites With Racial Disparities in Hypertension and Stroke in the REGARDS Study	47
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy–Related Inflammation	47
Author Response: Automated Quantitative Pupillometry in the Critically Ill: A Systematic Review of the Literature	47
Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States	47
Teaching NeuroImage: Cryptococcal Meningoencephalitis With Cryptococcoma and Gelatinous Pseudocysts	47
Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy–Associated Myopathies	47
Lysine Reduction and Cognitive Outcomes in Pyridoxine-Dependent Epilepsy	47
Influence of Hospital Type on Outcomes of Patients With Acute Spontaneous Intracerebral Hemorrhage	47
Association Between Time to Endovascular Therapy and Outcomes in Patients With Acute Basilar Artery Occlusion	47
Racial and Socioeconomic Disparities in Ischemic Stroke Outcomes among Non-lytic/Thrombectomy Patients (P7-5.008)	47
Author Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study	46
Teaching NeuroImage: Claustrum Sign in Febrile Infection–Related Epilepsy Syndrome	46
Acoustically Altered Speech Perception in Frontotemporal Dementia Syndromes	46
Performance Assessment of the New EUROLINE Neurologic Syndrome 15 Ag (IgG) for the Determination of Autoantibodies Associated with Neurological Disorders	46
Jugular Variant Bow-Hunter’s Syndrome from Sternocleidomastoid Entrapment of the Internal Jugular Vein (P11-10.001)	46
Editors' Note: Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study	46
Autoimmune Cerebellar Ataxia Associated with TNF-Alpha Blocking Therapy in a Patient with Rheumatoid Arthritis: A Case Report and Literature Review (P8-8.003)	45
A Case of Contrast-Induced Encephalopathy in The Setting of Acute Stroke Thrombolysis (P1-1.Virtual)	45
Variants in PNPLA8 are Associated with Developmental Epileptic Encephalopathy and Cerebellar Atrophy. (P6-5.002)	45

Group D Salmonella Meningitis in the Neonate (P5-6.010)	45
A Rare Case of Giant Cell Arteritis Presenting With Transient Polycranial Neuropathies (P6-12.004)	45
An IDH Wildtype, EGFR Amplified and TERT Promoter Mutated Astrocytoma that is Clinically and Molecularly Incompatible with the Diagnosis of Glioblastoma, IDH Wildtype. (P13-9.001)	45
Safety and Efficacy of Tenecteplase and Alteplase in Patients With Tandem Lesion Stroke	45
Nitrous Oxide-Induced Vitamin B12 Deficiency and Myelopathy: A Report of Two Cases (P11-2.006)	45
Accurate Test of Limb Isometric Strength (ATLIS) as an Outcome Measure in ALS and as a Marker of Upper Motor Neuron Involvement in Primary Lateral Sclerosis (S11.010)	45
Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)	44
Risk and Predictors of Relapse after Smoking Cessation in Patients with Ischemic Stroke and Transient Ischemic Attack (P1-1.Virtual)	44
Assessing Social Cognition Across Dementia Subtypes (P6-6.004)	44
Proteomic profiling of sporadic late-onset nemaline myopathy (P15-13.001)	44
Neuroradiological profile of Rhinoorbitocerebral mucormycosis in COVID-19 pandemic. (S18.007)	44
Lest We Forget: Ammonia in Encephalopathic Cancer Patients (P1-1.Virtual)	44
Functional Parcellation of the Cingulate Gyrus in Epilepsy Surgical Planning: Electrical stimulation, Electrocorticography, and fMRI study (P4-8.005)	44
Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood-Brain Barrier after Stroke (S33.001)	44
Anti-IgLON-5 Associated Neurological Disease Presenting with Bilateral Optic Neuritis, Orthostatic Intolerance, Sleep-Related Movements in Setting of Testicular Mass: Expanding Clinical Phenotypes in	44
Psychometric Evaluation of the Idiopathic Hypersomnia Severity Scale (P1-7.001)	43
Acute Anterograde Amnesia with Bilateral Hippocampal and Globus Pallidus Lesions (P4-12.007)	43
Experiences with a virtual nationwide seminar series for neuroimmunology trainees (P14-6.001)	43
Glymphatic Impairment in Multiple Sclerosis: A New Pathological Mechanism Associated with Disease Burden (S5.010)	43
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006)	43
Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant (P11-11.008)	43
In-Hospital Glucose Measurements are Associated with Mortality after Thrombectomy for Acute Ischemic Stroke (P4-10.005)	43
Impact of Multiple Sclerosis Disease-Modifying Therapies on Effectiveness of SARS-Cov-2 Vaccines: A Longitudinal Total Population Study of National Health Service (NHS) England (S5.008)	43
Determinants of Disparate Disability Accumulation in Black, Hispanic, and White Patients With Multiple Sclerosis (P1-1.Virtual)	42
Glucocerebrosidase Deficiency Mediates Propagation of Protein Aggregation in Neurodegeneration via Modification of Extracellular Vesicles (S36.006)	42
Iron accumulation correlates with disease severity in patients with Multiple System Atrophy (P15-11.002)	42
The Bulbar Imposter: A Case Presentation of Foix-Chavany-Marie Syndrome (P10-10.001)	42
Data-Driven Genome-Wide Association Study of Pain Trajectories in Persons with Parkinson’s Disease (P7-11.012)	41
Improving Residents’ Knowledge and Interest in Outpatient Neurology through an Interactive, Discussion-Based, Patient-Centered Didactic Series (P2-2.006)	41
Analysis of the Epidemiologic Profile, Prevalence, and Incidence of Migraine out of 15,490 Spontaneous Intracranial Hypotension Patients from a Multicenter Record Database (TriNetX) (P2-12.008)	41
Neurocognitive Manifestations of Individuals with NF1 Microdeletions (P14-9.007)	41
MOG Antibody-Associated Bilateral Optic Neuritis Associated with Johnson and Johnson COVID-19 Vaccination (P12-3.009)	41
Health Care Delivery and Financial Considerations in Amyotrophic Lateral Sclerosis Clinics	41
Serum Glucose Fluctuations Is an Independent Predictor of Adverse Outcomes in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment (P7-5.014)	41
Preclinical Development of a T Cell Receptor-engineered Regulatory T Cell Therapy for Progressive MS (S17.004)	40
Assessing Undergraduate Neurology Pipeline Programs: A Systematic Review (P11-2.001)	40
Changes in Myasthenia Gravis Incidence in Denmark From 1985 to 2021	40
Elevated Level of DNA Damage and Impaired Repair of DNA Oxidative Damage in Multiple Sclerosis Patients (P7-6.010)	40
MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes (P13-5.020)	40
Survival and Clinical Characteristics of Patients with Glioblastoma with Primitive Neuronal Component (P13-13.004)	40
African-Americans With Multiple Sclerosis Have a Higher Proportion of B-Cell Lineage Cells in Their Cerebrospinal Fluid (CSF) Than White Patients (P9-3.010)	40
Identification of a Novel NOTCH3 Mutation in a Case of CADASIL Initially Diagnosed as Demyelinating Disease (P3-3.010)	40
Machine-learning Assisted Swallowing Assessment: A Deep Learning-based Quality Improvement Tool to Screen for Post-stroke Dysphagia (S6.004)	40
Levamisole-associated Toxic Multifocal Inflammatory Leukoencephalopathy: A Case Report (P7-3.006)	39
Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment (P6-12.011)	39
Gadolinium Enhancement Patterns in Leptomeningeal Disease (P2-2.001)	39
Pathologically- confirmed Osmotic Demyelination in the Case of Clinically and Radiographically Progressive Encephalopathy due to Liver Disease and Malnutrition. (P4-4.007)	39
Patterns of Benzodiazepine Initiation Among Older Acute Ischemic Stroke Survivors (P1-10.006)	39
Evaluating Quality of Website-Derived Concussion Information (P8-1.005)	39
Patient Sera from the First Week Postpartum after Preeclampsia Increase Human Blood Brain Barrier Permeability (S25.003)	39
Metronidazole Induced Encephalopathy Responsive to High Dose Thiamine (P4-12.006)	38
COVID-19 Disrupts Sleep Architecture by Reducing N3 Stage Sleep (S25.010)	38
Designing Transgene Vectors for ALS Therapeutics (P11-4.010)	38
Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study (P13-5.003)	38
Tenecteplase Is a Better Alternative to Alteplase for Patients With Large Vessel Occlusion Stroke Receiving Bridging Therapy	38
Tuberculous Meningitis: Is the Fixed Dose Anti-TB treatment strategy effective? Case report from Sri Lanka (P3-10.002)	38
Reconsidering the Ethics of Provocation Techniques for Psychogenic Non-epileptic Seizures and Proposed Ethical Guidelines for Use (P2-10.005)	38
Development of eIF2B Activator ABBV-CLS-7262 as a Novel Treatment for Vanishing White Matter Disease (P2-8.001)	38
A Gender Affirming Experience; The RNS System Tracking Seizure Frequency During Gender Changing Hormonal Therapy (P5-9.006)	38
Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis (P14-3.017)	38
Recognizing Neuropathic Pain as a Symptom of Charcot-Marie-Tooth Disease that impacts Quality of Life (P14-8.005)	37
What’s that Mass? A Sphenoid Lesion Causing Cavernous Sinus Syndrome (P3-14.009)	37
Endovascular Therapy for NIHSS ≤5	37
Association of Subthalamic Beta Frequency Sub-bands to Symptom Severity in Patients with Parkinson’s Disease: A Systematic Review (P5-11.014)	37
‘Code Brain’- Mannequin Based Simulation Exercise to Enhance Identification, Evaluation, and Management of Cerebral Herniation for Neurology Residents. (P5-5.027)	37
A Ten-year Delayed Diagnosis of Hereditary Spastic Paraplegia Type-10: Key Clinical, Electrodiagnostic, and Genetic Findings (P11-11.004)	37
A pioneer in the History of Women in Neurology - Historical Review of the Life and Contributions of Augusta Déjerine-Klumpke (P4-11.009)	37
4 mA tDCS improves walking ability in PSP: A case study (P9-11.012)	37
Computational Models of Age-associated Cognitive Slowing and Memory Loss (P6-9.010)	37
Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia	37
Pearls & Oy-sters: Vocal Cord Palsy as the Presenting Manifestation of Neurosarcoidosis	37
Role of Pre-operative Mild Cognitive Impairment in Patients Undergoing Deep Brain Stimulation for Parkinson’s Disease: Systematic Review (P2-3.011)	36
The Path to Finding a Unifying Diagnosis – A Case Report of Mitchell Syndrome in a Pediatric Patient (P2-8.005)	36
The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004) (P4-14.017)	36
Multimodal Approach to NMOSD Relapse Treatment: Experience with Two Cases (P10-8.011)	36
Neuroimaging Evidence of Cortical-subcortical Network Involvement in Patients with Cortical Lateralized Periodic Discharges (P5-1.004)	36
7T MRI Leptomeningeal Enhancement and Brain Atrophy Are Associated with Alterations in Arginine-polyamine Metabolism in Multiple Sclerosis (P11-6.007)	36
Serum Neuroinflammatory Biomarkers and Long-term Cognitive Dysfunction (P11-13.002)	36
Personalized Alzheimer’s Risk Reduction Software Improves Calculated Alzheimer’s Risk: A Digital, Decentralized, Randomized Controlled Trial (P1-3.004)	36
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and Anti-N-Methyl-D-Aspartate Receptor Encephalitis (NMDARE) Overlapping Syndrome Presenting as Tics and Cognitive Symptoms (P10	36
Role of 18F-Florzolotau PET in Diagnostic and Therapeutic Decision-Making for Cognitive Impairment (N4.001)	36
Prospective Long-term Seizure Outcomes in Medically-resistant Focal Epilepsy Subjects with Neuromodulation Devices (P3-1.009)	35
Focal Cerebral CNS Vasculitis due to SARS-CoV-2 Infection (P4-10.007)	35
Pregnancy-related Anticipatory Guidance for People with Epilepsy in Pediatric and Adult Neurology (P1-9.015)	35
Impact of an Inpatient Stroke Education Program on Stroke Knowledge in Lusaka, Zambia (S24.005)	35
A Fatal Case of CNS Actinomyces Mimicking Tolosa-Hunt Syndrome: Is it Time to Reevaluate Diagnostic Criteria? (P10-10.004)	35
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables (P1-5.022)	35
Characteristics of Adult Essential Tremor Patients Seeking Participation in a Decentralized US Clinical Trial: Pre-screener Findings from the Essential3 Program Evaluating Efficacy and Safety of Ulixa	35
Perceived Stress and its Association with Sleep Quality in Patients with Neuropathic Pain and Distal Symmetric Polyneuropathy (P3-11.020)	35
Socioeconomic Disparities in Aspiration Pneumonia Hospitalizations in Parkinson’s Disease Patients (P2-5.006)	35
Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson’s Disease (P7-5.026)	35
Drug-Resistant GAD65-Associated Epilepsy: Pre-Surgical Evaluation and Comparison to Temporal Lobe Epilepsy of Other Etiology (P2-9.005)	35
Racial Disparities in Mental Health Among Stroke Survivors in the REDUCE Study (P1-13.014)	35
Unveiling the Diagnostic and Therapeutic Challenges: A Singular Case of Syphilitic Myelitis in an HIV-Positive Patient (P5-10.007)	35
Blood Pressure Variability as a Marker of Sympathetic Hyperreactivity in Postpartum Patients with Preeclampsia, with and without Chronic Hypertension (P2-7.003)	35